PP

Prabhakaran Pradeep

Active Director Director DIN 07074675
DIN 07074675 First appointment Mar 2015 Primary industry Information Technology
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Mar 2015
Shareholding value •••• Premium profile

About Prabhakaran Pradeep

Data last updated:

Prabhakaran Pradeep is a Director at Prakalp Ventures Private Limited (since 2015), Director at G-Cube Pharma Private Limited (since 2022) and Director at Purecirca Regenerative Technologies Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Information Technology, Chemicals and Cleantech. The 2 current companies with reported revenue have a combined latest revenue of ₹20.9 Lakh; the largest is Prakalp Ventures Private Limited at ₹11.8 Lakh (FY 2025). Earlier, Prabhakaran Pradeep was a Designated Partner at Ruderesh Polymer India Llp (2022–2024).

DIN 07074675
Primary Designation Director
Industry Information Technology
First Appointment 17 Mar 2015
Oldest Company Age 11 yrs
Largest company Prakalp Ventures Private Limited · ₹11.8 Lakh (FY 2025)
Combined revenue ₹20.9 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Prakalp Ventures Private Limited U24233TN2015PTC099692
Director17 Mar 20152015₹11.8 Lakh (FY 2025)Active
G-Cube Pharma Private Limited U24290TN2022PTC156012
Director14 Oct 20222022₹9.1 Lakh (FY 2025)Active
Director29 Mar 20252025Active
Chemprotect Infra Private Limited U74999TN2020PTC136032
Director28 Jun 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Aug 20222014Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Prakalp Ventures Private Limited
G-Cube Pharma Private Limited
Chemprotect Infra Private Limited
Purecirca Regenerative Technologies Private Limited
Premium access

Shareholding and investment profile for Prabhakaran Pradeep

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prabhakaran Pradeep

Prabhakaran Pradeep currently holds 4 directorships: Prakalp Ventures Private Limited (Director, since 17 Mar 2015, revenue ₹11.8 Lakh (FY 2025)); G-Cube Pharma Private Limited (Director, since 14 Oct 2022, revenue ₹9.1 Lakh (FY 2025)); Purecirca Regenerative Technologies Private Limited (Director, since 29 Mar 2025); Chemprotect Infra Private Limited (Director, since 28 Jun 2020).

Prabhakaran Pradeep was first appointed on 17 Mar 2015 as Director at Prakalp Ventures Private Limited. The most recent appointment on record is 29 Mar 2025 at Purecirca Regenerative Technologies Private Limited.

The 2 current companies of Prabhakaran Pradeep that report revenue have a combined latest revenue of ₹20.9 Lakh: Prakalp Ventures Private Limited ₹11.8 Lakh (FY 2025); G-Cube Pharma Private Limited ₹9.1 Lakh (FY 2025).

Prabhakaran Pradeep held 1 earlier board appointment: Ruderesh Polymer India Llp (Designated Partner, 19 Aug 2022 to 30 Mar 2024).

The current boards of Prabhakaran Pradeep's companies include Kalpana Devendiran (Prakalp Ventures Private Limited), Subachander (Prakalp Ventures Private Limited), Karthik (G-Cube Pharma Private Limited), Devaraj Jestin Roy (Purecirca Regenerative Technologies Private Limited), Nagarajan Revathy (Purecirca Regenerative Technologies Private Limited), Ranganathan Prabhakaran (Purecirca Regenerative Technologies Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available